Novartis Investigative Site

Hagerstown, Maryland 21742

0 studies enrolling now · 5 studies all time

What they study most

Ankylosing Spondylitis, Diabetic Macular Edema, Leukaemia, Lymphocytic, Chronic, Macular Edema, Multiple Sclerosis, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion

Studies at this site

• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients — Completed
• Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema — Completed
• Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis — Completed
• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early